Instil Bio, Inc. – NASDAQ:TIL
Instil Bio stock price today
$25.57
+5.52
+27.53%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Instil Bio stock price monthly change
+57.63%
month
Instil Bio stock price quarterly change
+57.63%
quarter
Instil Bio stock price yearly change
+168.79%
year
Instil Bio key metrics
Market Cap | 135.31M |
Enterprise value | 42.08M |
P/E | -0.36 |
EV/Sales | N/A |
EV/EBITDA | -0.12 |
Price/Sales | N/A |
Price/Book | 0.22 |
PEG ratio | 0.55 |
EPS | -18.97 |
Revenue | N/A |
EBITDA | -114.28M |
Income | -123.32M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInstil Bio stock price history
Instil Bio stock forecast
Instil Bio financial statements
| Jun 2023 | 0 | -18.66M | |
|---|---|---|---|
| Sep 2023 | 0 | -67.43M | |
| Dec 2023 | 7.67M | -12.92M | -168.51% |
| Mar 2024 | 0 | -24.30M |
| Mar 2024 | 0 | -24.30M | |
|---|---|---|---|
| Sep 2025 | 0 | -22.04M | |
| Oct 2025 | 0 | -25.36M | |
| Dec 2025 | 0 | -27.54M |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 408310000 | 111.79M | 27.38% |
|---|---|---|---|
| Sep 2023 | 340272000 | 106.24M | 31.22% |
| Dec 2023 | 325630000 | 99.80M | 30.65% |
| Mar 2024 | 306303000 | 100.47M | 32.8% |
| Jun 2023 | -19.56M | 10.33M | 4.20M |
|---|---|---|---|
| Sep 2023 | -14.42M | 2.31M | -587K |
| Dec 2023 | -13.38M | 13.95M | 1.01M |
| Mar 2024 | -14.39M | 9.24M | 0 |
Instil Bio alternative data
| Aug 2023 | 192 |
|---|---|
| Sep 2023 | 192 |
| Oct 2023 | 192 |
| Nov 2023 | 192 |
| Dec 2023 | 192 |
| Jan 2024 | 192 |
| Feb 2024 | 192 |
| Mar 2024 | 49 |
| Apr 2024 | 49 |
| May 2024 | 49 |
| Jun 2024 | 49 |
| Jul 2024 | 49 |
Instil Bio other data
48.33%
-30.07%
of TIL is owned by hedge funds
40
-34
62.59M
-39.07M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2021 | 2550000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | CROUCH BRONSON | Common Stock | 450,000 | $20 | $9,000,000 | ||
Purchase | MCGAUGHY R KENT JR | Common Stock | 450,000 | $20 | $9,000,000 | ||
Purchase | VIVO CAPITAL IX, LLC | Common Stock | 300,000 | $20 | $6,000,000 | ||
Purchase | CURATIVE VENTURES V LLC | Common Stock | 450,000 | $20 | $9,000,000 | ||
Purchase | NIELSEN JACK | Common Stock | 300,000 | $20 | $6,000,000 | ||
Purchase | SHAH NIMISH P | Common Stock | 300,000 | $20 | $6,000,000 | ||
Purchase | SHAH NIMISH P | Common Stock | 300,000 | $20 | $6,000,000 |
-
What's the price of Instil Bio stock today?
One share of Instil Bio stock can currently be purchased for approximately $25.57.
-
When is Instil Bio's next earnings date?
Unfortunately, Instil Bio's (TIL) next earnings date is currently unknown.
-
Does Instil Bio pay dividends?
No, Instil Bio does not pay dividends.
-
How much money does Instil Bio make?
Instil Bio has a market capitalization of 135.31M.
-
What is Instil Bio's stock symbol?
Instil Bio, Inc. is traded on the NASDAQ under the ticker symbol "TIL".
-
What is Instil Bio's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Instil Bio?
Shares of Instil Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Instil Bio's key executives?
Instil Bio's management team includes the following people:
- Mr. Bronson Crouch Chairman & Chief Executive Officer(age: 52, pay: $2,370,000)
- Dr. Zachary Roberts M.D., Ph.D. Chief Medical Officer(age: 47, pay: $810,690)
- Dr. Sandeep Laumas M.D. Chief Financial Officer & Chief Bus. Officer(age: 56, pay: $639,180)
-
How many employees does Instil Bio have?
As Jul 2024, Instil Bio employs 49 workers.
-
When Instil Bio went public?
Instil Bio, Inc. is publicly traded company for more then 4 years since IPO on 19 Mar 2021.
-
What is Instil Bio's official website?
The official website for Instil Bio is instilbio.com.
-
Where are Instil Bio's headquarters?
Instil Bio is headquartered at 3963 Maple Avenue, Dallas, TX.
-
How can i contact Instil Bio?
Instil Bio's mailing address is 3963 Maple Avenue, Dallas, TX and company can be reached via phone at +972 4993350.
Instil Bio company profile:
Instil Bio, Inc.
instilbio.comExchange:
NASDAQ
Full time employees:
49
Industry:
Biotechnology
Sector:
Healthcare
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
3963 Maple Avenue
Dallas, TX 75219
Dallas, TX 75219
CIK: 0001789769
ISIN: US45783C2008
CUSIP: 45783C101
